To The Moon

In 2023, overseas markets excelled, especially in the U.S., where major broad-based indices in the stock market achieved remarkable results. As 2024 begins, the technology sector in the U.S. experiences an upward trend due to exceptional macroeconomic performance, driven by the AIGC concept and ample liquidity, resulting in strong performances from various software and semiconductor technology stocks. Closelook@US Stock Markets Looking ahead to 2024, the US macroeconomic environment seems poised for a "soft landing." Factors contributing to the robust economic performance include resilient consumer spending, technological advancements stimulating corporate investments, and the US government's efforts to bring manufacturing back, fostering economic recovery. With inflation decreasing, interest rates falling, and a stable economic growth rate, the foundation for a bullish US stock market has been established. Investors are particularly advised to focus on the $NASDAQ 100(NDX)$ , which, in 2023, reached historic highs driven by favorable economic cycles, macroeconomic resilience, and the innovation catalyst brought by AI developments, notably driven by ChatGPT. Additionally, the S&P Biotechnology sector presents an attractive investment opportunity in 2024. The biotech industry, a focal point of recent technological and industrial revolutions, shows vast potential. Favorable factors include strong acquisition intentions from major pharmaceutical companies, historically low industry valuations, potential interest rate cuts by the Federal Reserve, and the FDA's progressive approvals. Within the biotech sector, the S&P Biotechnology Select Industry Index, with its equal-weighted allocation and focus on smaller yet innovative U.S. biotech companies, stands out as a compelling choice for investors. The US healthcare market's high per capita spending and strong revenue streams have historically benefited pharmaceuticals, biotech, and medical devices sectors. In conclusion, considering the excellent performance of the US stock market in recent years and aligning with macroeconomic fundamentals and fiscal policies, a bullish outlook is favored for the technology sector in 2024. The recommended ETFs are the $NASDAQ 100(NDX)$ and the $Direxion Daily S&P Biotech Bull 3x Shares(LABU)$. Diversifying assets globally is also encouraged for a well-rounded portfolio, providing exposure to different economies and mitigating risks through low correlation between assets. Disclaimer: Information provided is for informational purposes only, not financial advice. Investing involves risks; consider consulting a financial advisor.